CapsoVision anticipates FDA clearance for AI Highlights by end of Q3 as it targets Q4 CapsoCam Colon submission — See source for full details.
$CV
Price history, market instrument context, member research, and related headlines in one place.
CV key statistics
NasdaqCMUSD
52-week range
$4.5018%$15.37
Latest session $6.24–$6.75CapsoVision, Inc. (CV) is a stock instrument quoted on NasdaqCM in USD. The most recently published price is $6.45, down $0.19 (2.86%) from the previous close of $6.64. It has traded between $6.24 and $6.75 in the latest session. Over the past year it has ranged from $4.50 to $15.37, leaving it in the lower quarter of its 52-week range (18%). Reported volume for the session was 170K. Figures are the latest published by the exchange feed and are not a recommendation.
Primary market bars from Yahoo Finance · Extended-hours prints appear when supplied by the venue · Interactive charts powered by TradingView Lightweight Charts™ · Not a recommendation
Source-linked intelligence
Related news
CapsoVision launches AI feature for capsule endoscopy abroad — See source for full details.
Loading $CV research…